G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $93,000 | +9.4% | 3,536 | -5.4% | 0.00% | 0.0% |
| Q3 2019 | $85,000 | -12.4% | 3,736 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $97,000 | +120.5% | 3,166 | +18.8% | 0.00% | – |
| Q1 2019 | $44,000 | -13.7% | 2,666 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -64.8% | 2,666 | -3.6% | 0.00% | -100.0% |
| Q3 2018 | $145,000 | +0.7% | 2,766 | -29.1% | 0.00% | 0.0% |
| Q2 2018 | $144,000 | 0.0% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $144,000 | +166.7% | 3,900 | +44.4% | 0.00% | 0.0% |
| Q4 2017 | $54,000 | -5.3% | 2,700 | +17.4% | 0.00% | 0.0% |
| Q3 2017 | $57,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |